-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
GOLDENWELL BIOTECH, INC. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2019 to 30 Jun 2025.
- GOLDENWELL BIOTECH, INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 30 Jun 2025 was $0, a 100% decline year-over-year.
- GOLDENWELL BIOTECH, INC. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $119,250, a 0.94% decline from 2023.
- GOLDENWELL BIOTECH, INC. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $120,388, a 87% decline from 2022.
- GOLDENWELL BIOTECH, INC. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $905,000, a 432% increase from 2021.